- Market Capitalization, $K 713,702
- Shares Outstanding, K 144,474
- Annual Sales, $ 24,000 K
- Annual Income, $ -58,570 K
- 60-Month Beta 1.46
- Price/Sales 30.29
- Price/Cash Flow N/A
- Price/Book 5.23
|Period||Period Low||Period High||Performance|
| || |
+0.98 (+24.75%)since 08/24/21
| || |
+0.12 (+2.49%)since 06/24/21
| || |
+3.49 (+240.69%)since 09/24/20
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, Lexicon's president and chief executive officer, will present virtually at the Oppenheimer Fall Healthcare Life Sciences...
New guidelines from the European Society of Cardiology recommend addition of SGLT inhibitors to standard of care for patients with acute and chronic heart failure.
Rapid benefit of sotagliflozin supported by data from the SOLOIST and SCORED trials presented at ESC Congress 2021 - The Digital Experience, including:
Lexicon (LXRX) delivered earnings and revenue surprises of 18.75% and 680.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
THE WOODLANDS, Texas (AP) _ Lexicon Pharmaceuticals Inc. (LXRX) on Friday reported a loss of $18.1 million in its second quarter.
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today announced that Craig Granowitz, M.D., Ph.D. will join the company as senior vice president and chief medical officer, effective August 2, 2021.
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended June 30, 2021 and provided an update on key milestones.
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will release its second quarter 2021 financial results on Friday, July 30, 2021 before the markets open. Management will conduct a conference call and live...
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today there will be a symposium highlighting sotagliflozin followed by a live video question and answer period during the American Diabetes Association's...
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats, Lexicon's president and chief executive officer, will present at the 2021 Jefferies Virtual Healthcare Conference on Wednesday,...
|Bioshares Biotech Clinical Trial|
|Principal Healthcare Innovators Index|
|Micro-Cap Ishares ETF|
|Victory US Disc Enhd Vol Wtd ETF|
|Victory US Smallcap Vol Wtd ETF|